USPTO serial 79395398
U
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- THOMAS, AMY E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with U?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 East 42nd StreetSuite 1250New York, NY 10165Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable textual, audio, visual and audio-visual files in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable podcasts in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable video podcasts in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable electronic publications in the nature of downloadable books, downloadable magazines and downloadable articles in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus | ACTIVE | — |
| 035 | Advertising services; marketing services; publicity agency services; market analysis and research services; brand creation services in the nature of brand conception, development, evaluation, positioning, strategy and brand testing services in the nature of conducting market studies for consumer reaction to branding; design and development of marketing, publicity and advertising strategies and materials; providing information, advisory and consultancy services regarding advertising, marketing, publicity and regarding market analysis and research; providing information, advisory and consultancy services in the nature of market analysis and research regarding brand creation, evaluation, positioning, strategy and testing in the nature of market research; providing information, advisory and consultancy services relating to the design and development of marketing strategies and materials, development of publicity strategies and materials and relating to the development of advertising strategies and materials | ACTIVE | — |
| 039 | Providing information, advisory and consultancy services in the fields of transportation and delivery of pharmaceuticals | ACTIVE | — |
| 040 | Providing information, advisory and consultancy services in the field of manufacture of pharmaceuticals | ACTIVE | — |
| 041 | Arranging, organising and conducting workshops, symposia, talks, lectures, seminars, courses and programmes in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; provision of online non-downloadable textual, audio, visual and audio-visual content and materials in the nature of videos, e-zines and articles in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; providing information, advisory and consultancy services in the fields of education and business training | ACTIVE | — |
| 042 | Brand design services, namely the design of corporate identities in the nature of the graphic design of logos, typography, icons, color schemes, and key visuals; providing information, advisory and consultancy services relating to brand design, namely to the design of corporate identities in the nature of the graphic design of logos, typography, icons, color schemes, and key visuals; providing information, advisory and consultancy services regarding quality assurance and quality management in the fields of clinical studies, clinical practice and of clinical laboratory practice; providing information, advisory and consultancy services regarding clinical studies, clinical practice and regarding clinical laboratory practice; auditing in the nature of product and service quality evaluation and quality control services for others relating to pharmacovigilance, namely to the prevention, diagnosis and treatment of adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines, instruments, equipment and apparatus, relating to medicine, healthcare, pharmacy, biotechnology and to medical devices, machines, instruments, equipment and apparatus; quality control services for others undertaking their own advertising, marketing, publicity and market analysis and research; quality control services for others undertaking their own brand creation, evaluation, positioning, strategy and testing; quality control services for others undertaking their own design and development of marketing strategies and materials, design and development of publicity strategies and materials and their own design and development of advertising strategies and materials; auditing in the nature of quality evaluation and analysis, quality assurance and quality control for others in the fields of transportation and delivery of pharmaceuticals; auditing in the nature of quality evaluation and analysis, quality assurance and quality control for others undertaking education and training of their workforce and for other providing educational and training services | ACTIVE | — |
| 044 | Providing information, advisory and consultancy services regarding pharmacovigilance, namely preventing, diagnosing and treating adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines or instruments, and regarding medicine, healthcare, pharmacy, biotechnology and regarding medical devices, machines, instruments, equipment and apparatus | ACTIVE | — |
| 045 | Providing information, advisory and consultancy services regarding legal affairs, regulatory affairs, legal inspections, legal audits and regarding governmental regulatory inspections and audits in the fields of pharmacovigilance, namely preventing, diagnosing and treating adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines or instruments, and in the fields of medicine, healthcare, pharmacy, biotechnology and in the field of medical devices, machines, instruments, equipment and apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Uptake Strategies Limited
- Other trademarks owned by Uptake Strategies Limited
- Other trademarks owned by Uptake Strategies Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named U
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 8, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 8, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 27, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 10, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 18, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 29, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 9, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 22, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 22, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 22, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 22, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 20, 2024 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |